Skip to main content
Log in

Radioiodinated Azilsartan as a New Highly Selective Radiotracer for Myocardial Perfusion Imaging

  • Published:
Radiochemistry Aims and scope

Abstract

Azilsartan (AZ) was labeled with 131I using Chloramine-T as oxidizing agent. Factors affecting the labeling efficiency were systematically studied, and optimum conditions were found: oxidizing agent amount 100 μg, substrate amount 100 μg, pH 6, reaction time 30 min, and ambient temperature. Biodistribution studies showed that [131I]iodoAZ is concentrated in heart at 5 min post-injection to give high uptake of 29.0 ± 0.6% injected dose/g organ. Thus, iodoAZ shows promise as a radiotracer for heart imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1.
Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

REFERENCES

  1. Austria-Codex, Haberfeld, H., Ed., Vienna: Österreichischer Apothekerverlag, 2015.

  2. Arzneistoff-Profile, Dinnendahl, V. and Fricke, U., Eds., Eschborn, Germany: Govi Pharmazeutischer, 2012.

  3. Cerqueira, M.D., Glob. J. Child Res., 2003, pp. 1448–1453.

  4. Budoff, M.J. et al., J. Am. Coll. Cardiol., 2005, vol. 46, p. 383.

    Article  Google Scholar 

  5. Bateman, T., Dilsizian, V., Beanlands, R., DePuey, E.G., Heller, G., and Wolinsky, D., J. Nucl. Med., 2016, vol. 57, no. 10, p. 1654.

    Article  Google Scholar 

  6. Baggish, A.L. and Boucher, C.A., Circulation, 2008, vol. 118, no. 16, p. 1668.

    Article  Google Scholar 

  7. Sanad, M.H., Sallam, Kh.M., Marzook, F.A., and Abd-Elhaliem, S.M., J. Label. Compd. Radiopharm., 2016, vol. 59, p. 48.

    Article  Google Scholar 

  8. Sanad, M.H., Ebtisam, A.M., and Safaa, B.C., Radiochim. Acta, 2018, vol. 106, no. 4, pp. 329–336.

    Article  CAS  Google Scholar 

  9. Sanad, M.H. and Alhussein, A., Radiochim. Acta, 2018, vol. 106, no. 10, pp. 843–850.

    Article  CAS  Google Scholar 

  10. Sanad, M.H., Marzook, F.A., and Abd-Elhaliem, S.M., Radiochim. Acta, 2021, vol. 109, no. 1, pp. 41–46.

    Article  CAS  Google Scholar 

  11. El-Tawoosy, M., Farouk, N., and El-Bayoumy, A.S., J. Radioanal. Nucl. Chem., 2011, vol. 290, pp. 595–600.

    Article  CAS  Google Scholar 

  12. Amin, A., Abd El-Bary, A., Abd El-Mohty, A., Shokry, S., and El-Sharawy, M., J. Nat. Sci., 2013, vol. 5, no. 4, pp. 526–531.

    Google Scholar 

  13. Bissessor, N. and White, H., Vasc. Health Risk Manag., 2007, vol. 3, no. 4, pp. 425–430.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. El-Sharawy, D.M.M., Radioiodination and Bioevaluation of Some Cardiovascular Drugs for Nuclear Medicine Application: Thesis, Egypt: Cairo Univ., Faculty of Pharmacy, Department of Pharmaceutics and Industrial Pharmacy, 2013.

  15. Ibrahim, I.T. and Sanad, M.H., Radiochemistry, 2013, vol. 55, no. 3, pp. 336–339.

    Article  CAS  Google Scholar 

  16. . Sanad, M.H., Saleh, G.M., and Marzook, F.A., J. Label. Compd. Radiopharm., 2017, vol. 60, pp. 600–607.

    Article  CAS  Google Scholar 

  17. Sanad, M.H., Salama, D.H., and Marzook, F.A., Radiochim. Acta, 2017, vol. 105, pp. 389–398.

    Article  CAS  Google Scholar 

  18. Sanad, M.H. and Challan, S.B., Radiochemistry, 2017, vol. 59, pp. 307–312.

    Article  CAS  Google Scholar 

  19. Abolfazl, H., Mohammad, A.K., Masoumeh, H., and Mahmoud, T.A., Monatsh. Chem., 2012, vol. 143, pp. 619–623.

    Article  Google Scholar 

  20. Mohammad, A.K., Abolfazl, H., Iran J Org Chem., 2009,vol. 4, pp. 268–270.

    Google Scholar 

  21. Sanad, M.H., Farag, A.B., Salama, D.H., Journal of Labelled Compounds and Radiopharmaceuticals, 2018, vol. 61, pp. 501–508.

    Article  CAS  Google Scholar 

  22. Borai, E., Sanad, M.H., and Fouzy, A.S.M., Radiochemistry, 2016, vol. 58, no. 1, pp. 84–91.

    Article  CAS  Google Scholar 

  23. Sanad, M.H. and Emad, H.B., Radiochim. Acta, 2015, vol. 103(12), pp. 879–891.

    Article  CAS  Google Scholar 

  24. Sanad, M.H. and El-Tawoosy, M., Radioanalytical and Nuclear Chemistry, 2013, vol. 298(2), pp. 1105–1109.

    Article  CAS  Google Scholar 

  25. Amin, A.M., Sanad, M.H., Abd-Elhaliem, S.M., Radiochemistry, 2013, vol. 55, pp. 624–628. https://doi.org/10.1134/S1066362213060118

    Article  CAS  Google Scholar 

  26. Ebtisam, A.M., Ahmed, S.E., and Fawzy, A.M., Journal of Radiation Research and Applied Sciences, 2019, vol. 12(1), pp. 304–310. https://doi.org/10.1134/S1066362213060118

    Article  CAS  Google Scholar 

  27. Sanad, M.H. and Ibrahim, I.T., Radiochemistry, 2015, vol. 57, pp. 425–430. https://doi.org/10.1134/S1066362215040165

    Article  CAS  Google Scholar 

  28. Sanad, M.H., El-Bayoumy, A.S.A., and Alhussein, I.A., J. Radioanal. Nucl. Chem., 2017, vol. 311(1), pp. 1–14.

    Article  CAS  Google Scholar 

Download references

ACKNOWLEDGMENTS

This work was supported by STDF – National Research Centre under project number 41535 – PI Ahmed Sayed Morsy Fouzy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. F. A. Rizvi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanad, M.H., Marzook, F.A., Rizvi, S.F.A. et al. Radioiodinated Azilsartan as a New Highly Selective Radiotracer for Myocardial Perfusion Imaging. Radiochemistry 63, 520–525 (2021). https://doi.org/10.1134/S1066362221040160

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1066362221040160

Keywords:

Navigation